Phosphorex

Phosphorex provides drug delivery solutions to the pharmaceutical and biopharmaceutical industries, which include drug encapsulation, nanosizing, microemulsion, and surface functionalization and coating. Following is a brief summary of our expertise: Microencapsulation/nanoencapsulation of small molecule active pharmaceutical ingredients (APIs) or biomolecules into biodegradable microspheres or nanoparticles enables controlled or sustained drug release, protecting APIs from premature degradation as well as increasing circulation time and targeted drug delivery. Nanosizing can help you transform poorly soluble APIs with low bioavailability into nanocrystals that can be delivered more easily with enhanced solubility and bioavailability. Microemulsion, in which a poorly soluble API is dissolved in...

Drug delivery,nanoparticles,microspheres,polymeric nanoparticles,controlled release,targeted drug delivery,solubility enhancement,lnps,pnps,lipids nano particles,long acting injectables,particle-based formulation,cdmo,formulation of nrnas & dnas,vaccine development,gene delivery,oligonucleotide,pharma,biotech,drug release,and mrnas

Phosphorex operates in the Biotechnology research industry.

Phosphorex's revenue is 11m - 100m

Phosphorex has 11 - 50 employees.